In a structured follow-up of patients with early RA, patients experiencing unacceptable pain with low inflammation (CRP<10 mg/l) after 5 years were more likely to be ACPA-negative [59] (Fig. 4), suggesting that non-inflammatory long lasting pain may be a greater problem in this subset. This evidence concerns the gene PRTN3 and rheumatoid arthritis.